Guolin Xu

Dr. Guolin Xu is a Senior Research Engineer and Team Leader at KFSHRC. He has over 20 years of experience in bioengineering, medical device innovation, and technology commercialization. He earned his Ph.D. in Microfluidic Devices from Nanyang Technological University, Singapore, and has successfully translated research into clinically impactful healthcare technologies.

Dr. Xu has filed 17 patents, with 12 granted. Among these patents 7 are commercialized or licensed. His collaborative inventions, U.S. Patent US6573622B2 and Singapore Patent SG0125972A1, have been commercialized by Akribis Systems Pte Ltd and PBA Systems Pte Ltd, which together employ over 2,000 people. His collaborative U.S. Patents US8343443B2, US9707563B2 and US11142790 have also been licensed to a publicly listed U.S. company.

He has authored 34 peer-reviewed journal publications and received the Asia Innovation Silver Award (The Wall Street Journal Asia, 2011), the Best Oral Presentation Paper Award (Singapore, 2025), and the Best Innovation Paper Award (Thailand, 2025) with his co-workers.

Microfluidic devices for cell, DNA/RNA, and protein manipulation

Rare cell isolation and separation technologies

Body fluid management and therapeutic medical devices

Clinical laboratory and healthcare system automation

Medical device innovation, translational research, and commercialization

Dr. Gulin Xu earned a B.Eng. in Precision Instrument Engineering from Tsinghua University, China, an M.Eng. in Microelectromechanical Systems (MEMS) from the National University of Singapore under a full scholarship, and a Ph.D. in Biomedical Microfluidic Devices from Nanyang Technological University, Singapore, supported by the Scientific Staff Development Scheme Award.

He joined King Faisal Specialist Hospital & Research Centre in July 2026. Previously, he served as Vice President of Akribis Systems and Managing Director of Arogi Healthcare, leading multidisciplinary teams in the development and commercialization of innovative medical technologies.

From 2003 to 2019, he progressed from Research Officer to Senior Research Scientist at the Institute of Bioengineering and Nanotechnology (A*STAR), where he specialized in microfluidics, biomedical engineering, molecular diagnostics, rare cell isolation, and smart healthcare devices. Earlier, he worked as a Project Engineer developing precision motion control systems and co-inventing patented technologies.